
Diarrhea: Difference between revisions
>Graham m References heading |
>Graham m wiki ref formatting |
||
(8 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
<onlyinclude>[[File:Nhs-stool-chart.gif|300px|thumbnail|right|A type 6 - 7 stool can be classified as diarrhea.]] | <onlyinclude>[[File:Nhs-stool-chart.gif|300px|thumbnail|right|A type 6 - 7 stool can be classified as diarrhea.]] | ||
'''Diarrhea''' or '''diarrhoea''' is the condition of having at least three loose or liquid bowel movements each day. It often lasts for a few days and can result in [[dehydration]] due to fluid loss. This can progress to decreased urination, loss of skin | '''Diarrhea''' or '''diarrhoea''' is the condition of having at least three loose or liquid bowel movements each day. It often lasts for a few days and can result in [[dehydration]] due to fluid loss. This can progress to decreased urination, loss of skin colour, a fast heart rate, and a decrease in responsiveness as it becomes more severe. In the context of [[psychoactive substance]] usage, certain compounds have been known to induce diarrhea or can at least increase the likelihood of it occurring.<ref>{{cite journal | vauthors=((Tanaka, E.)), ((Kamata, T.)), ((Katagi, M.)), ((Tsuchihashi, H.)), ((Honda, K.)) | journal=Forensic Science International | title=A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy | volume=163 | issue=1–2 | pages=152–154 | date= November 2006 | url=https://linkinghub.elsevier.com/retrieve/pii/S0379073805006298 | issn=03790738 | doi=10.1016/j.forsciint.2005.11.026}}</ref><ref>{{cite journal | vauthors=((Shulgin, A. T.)), ((Carter, M. F.)) | journal=Communications in Psychopharmacology | title=N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity | volume=4 | issue=5 | pages=363–369 | date= 1980 | issn=0145-5699}}</ref><ref>{{cite journal | vauthors=((Muller, A. A.)) | journal=Journal of Emergency Nursing | title=New Drugs of Abuse Update: Foxy Methoxy | volume=30 | issue=5 | pages=507–508 | date= October 2004 | url=https://linkinghub.elsevier.com/retrieve/pii/S0099176704004556 | issn=00991767 | doi=10.1016/j.jen.2004.07.037}}</ref> This is not as dangerous as the same condition when it occurs through infection as it only remains until the person is no longer under the influence of the drug. | ||
Diarrhea is often accompanied by other coinciding effects such as [[nausea]] and [[dehydration]]. It is most commonly induced under the influence of [[dosage#common|heavy]] [[dosage|dosages]] of certain [[psychedelic]] compounds, such as [[ayahuasca]], [[mescaline]], and [[psilocybin mushrooms]]. However, it can also occur under the influence of certain [[stimulants]], [[modafinil]], and [[caffeine]]. | |||
</onlyinclude> | |||
===Psychoactive substances=== | ===Psychoactive substances=== | ||
Compounds within our [[psychoactive substance index]] which may cause this effect include: | Compounds within our [[psychoactive substance index]] which may cause this effect include: | ||
{{#ask:[[Category:Psychoactive substance]][[Effect::Diarrhea]]|format=ul|Columns= | {{#ask:[[Category:Psychoactive substance]][[Effect::Diarrhea]]|format=ul|Columns=2}} | ||
===Experience reports=== | |||
Annectdotal reports which describe this effect with our [[experience index]] include: | |||
{{#ask:[[Category:Experience]][[Effect::Diarrhea]]|format=ul|Columns=2}} | |||
===See also=== | ===See also=== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
Line 16: | Line 20: | ||
===References=== | ===References=== | ||
<references/> | <references/> | ||
[[Category:Uncomfortable]][[Category: | [[Category:Physical]][[Category:Uncomfortable]][[Category:Bodily]][[Category:Effect]] |
Latest revision as of 05:19, 4 June 2022

Diarrhea or diarrhoea is the condition of having at least three loose or liquid bowel movements each day. It often lasts for a few days and can result in dehydration due to fluid loss. This can progress to decreased urination, loss of skin colour, a fast heart rate, and a decrease in responsiveness as it becomes more severe. In the context of psychoactive substance usage, certain compounds have been known to induce diarrhea or can at least increase the likelihood of it occurring.[1][2][3] This is not as dangerous as the same condition when it occurs through infection as it only remains until the person is no longer under the influence of the drug.
Diarrhea is often accompanied by other coinciding effects such as nausea and dehydration. It is most commonly induced under the influence of heavy dosages of certain psychedelic compounds, such as ayahuasca, mescaline, and psilocybin mushrooms. However, it can also occur under the influence of certain stimulants, modafinil, and caffeine.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 2-FA
- 2C-B-FLY
- 2C-T-2
- 2C-T-21
- 2C-T-7
- 3-FEA
- 3C-E
- 3C-P
- 5-Hydroxytryptophan
- 5-MeO-DiPT
- 5-MeO-MiPT
- Ayahuasca
- Baclofen
- Bromo-DragonFLY
- Cannabidiol
- Creatine
- DOB
- DOC
- DOI
- DOM
- Harmala alkaloid
- MDPV
- Modafinil
- N-Methylbisfluoromodafinil
- Phenibut
- Prolintane
- SAM-e
Experience reports
Annectdotal reports which describe this effect with our experience index include:
See also
- Responsible use
- Subjective effects index
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects
External links
References
- ↑ Tanaka, E., Kamata, T., Katagi, M., Tsuchihashi, H., Honda, K. (November 2006). "A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy". Forensic Science International. 163 (1–2): 152–154. doi:10.1016/j.forsciint.2005.11.026. ISSN 0379-0738.
- ↑ Shulgin, A. T., Carter, M. F. (1980). "N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity". Communications in Psychopharmacology. 4 (5): 363–369. ISSN 0145-5699.
- ↑ Muller, A. A. (October 2004). "New Drugs of Abuse Update: Foxy Methoxy". Journal of Emergency Nursing. 30 (5): 507–508. doi:10.1016/j.jen.2004.07.037. ISSN 0099-1767.